中国执业药师
中國執業藥師
중국집업약사
CHINA LICENSED PHARMACIST
2014年
1期
7-9,15
,共4页
抗抑郁药%药物利用%处方分析
抗抑鬱藥%藥物利用%處方分析
항억욱약%약물이용%처방분석
Antidepressant%Drug utilization%Prescription analysis
目的:研究我院抗抑郁药的应用情况。方法:选取我院门诊2012年7-9月1080张诊断为抑郁症的处方进行分析。结果:1080例患者中,男425例(39.35%),女655例(60.65%),女性多于男性。各类抗抑郁药中,以选择性5-羟色胺再摄取抑制剂(SSRI)使用频率最高。各种抗抑郁药的平均使用剂量均在安全范围之内。697例(64.54%)患者联用苯二氮类药物治疗,476例(44.07%)患者联用抗精神病药,233例(21.57%)患者联用心境稳定剂。结论:以SSRI为主的新型抗抑郁药已经成为我院临床抗抑郁治疗的主流药物,抗抑郁药的使用以单一用药为主。
目的:研究我院抗抑鬱藥的應用情況。方法:選取我院門診2012年7-9月1080張診斷為抑鬱癥的處方進行分析。結果:1080例患者中,男425例(39.35%),女655例(60.65%),女性多于男性。各類抗抑鬱藥中,以選擇性5-羥色胺再攝取抑製劑(SSRI)使用頻率最高。各種抗抑鬱藥的平均使用劑量均在安全範圍之內。697例(64.54%)患者聯用苯二氮類藥物治療,476例(44.07%)患者聯用抗精神病藥,233例(21.57%)患者聯用心境穩定劑。結論:以SSRI為主的新型抗抑鬱藥已經成為我院臨床抗抑鬱治療的主流藥物,抗抑鬱藥的使用以單一用藥為主。
목적:연구아원항억욱약적응용정황。방법:선취아원문진2012년7-9월1080장진단위억욱증적처방진행분석。결과:1080례환자중,남425례(39.35%),녀655례(60.65%),녀성다우남성。각류항억욱약중,이선택성5-간색알재섭취억제제(SSRI)사용빈솔최고。각충항억욱약적평균사용제량균재안전범위지내。697례(64.54%)환자련용분이담류약물치료,476례(44.07%)환자련용항정신병약,233례(21.57%)환자련용심경은정제。결론:이SSRI위주적신형항억욱약이경성위아원림상항억욱치료적주류약물,항억욱약적사용이단일용약위주。
Objective:To evaluate the utilization of antidepressants in our hospital. Methods:The prescription analy-sis was conducted of 1 080 depression outpatients during Jul.-Sep. of 2012. Results:Of the selected patients female and male patients were 655(60.65%) and 425(39.35%) respectively. Among the antidepressants used,selective serotonin re-uptake inhibitors (SSRIs) were the most frequently used.The average dose of various antidepressants was all within the range of safety. The frequency of combined use of benzodiazepines,antipsychotics and mood stabilizers used was 64.54%, 44.07%and 21.57%respectively. Conclusion:New types of antidepressants based on SSRIs have become the mainstream treatment of depression in our hospital and antidepressants were mainly used as the single agent.